Delaware (State or other jurisdiction of incorporation or organization) | 2836 (Primary Standard Industrial Classification Code Number) | 27-0072226 (I.R.S. Employer Identification Number) |
Large accelerated filer | o | Accelerated filer | o | |
Non-accelerated filer | x (Do not check if a smaller reporting company) | Smaller reporting company | o |
Exhibit number | Description of exhibit | ||
31.1 | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32.1 | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
ACCELERON PHARMA INC. | ||
Date: August 12, 2014 | By: | /s/ JOHN L. KNOPF, PH.D. |
John L. Knopf, Ph.D. | ||
Chief Executive Officer and President | ||
Date: August 12, 2014 | By: | /s/ KEVIN F. MCLAUGHLIN |
Kevin F. McLaughlin | ||
Chief Financial Officer |
Exhibit number | Description of exhibit | ||
31.1 | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
32.1 | Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
August 12, 2014 | /s/ John L. Knopf | |
Date | John L. Knopf, Ph D. | |
Chief Executive Officer and President |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
August 12, 2014 | /s/ Kevin F. McLaughlin | |
Date | Kevin F. McLaughlin | |
Chief Financial Officer |
Date: August 12, 2014 | By: | /s/ John L. Knopf |
John L. Knopf PhD | ||
President and Chief Executive Officer | ||
(Principal Executive Officer) | ||
Date: August 12, 2014 | By: | /s/ Kevin F. McLaughlin |
Kevin F. McLaughlin | ||
Chief Financial Officer | ||
(Principal Financial Officer) |